Cooper Companies Inc (NYSE:COO) Director Allan E. Rubenstein sold 1,775 shares of Cooper Companies stock in a transaction on Friday, March 17th. The shares were sold at an average price of $195.00, for a total value of $346,125.00. Following the transaction, the director now directly owns 9,569 shares of the company’s stock, valued at $1,865,955. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Cooper Companies Inc (NYSE:COO) traded up 0.56% on Monday, hitting $196.24. The company had a trading volume of 411,288 shares. Cooper Companies Inc has a 12-month low of $141.67 and a 12-month high of $201.83. The firm has a market capitalization of $9.60 billion, a PE ratio of 32.34 and a beta of 0.56. The firm has a 50-day moving average price of $192.61 and a 200-day moving average price of $181.49.
Cooper Companies (NYSE:COO) last issued its quarterly earnings data on Thursday, March 2nd. The medical device company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.06. Cooper Companies had a return on equity of 15.38% and a net margin of 13.93%. The firm had revenue of $499.10 million for the quarter, compared to analyst estimates of $501.59 million. During the same period in the prior year, the firm posted $1.83 EPS. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. On average, equities research analysts anticipate that Cooper Companies Inc will post $9.24 earnings per share for the current fiscal year.
Your IP Address:
A number of hedge funds and other institutional investors have recently modified their holdings of COO. Norges Bank purchased a new position in shares of Cooper Companies during the fourth quarter worth approximately $85,142,000. Jarislowsky Fraser Ltd purchased a new position in shares of Cooper Companies during the fourth quarter worth approximately $1,436,000. United Capital Financial Advisers LLC purchased a new position in shares of Cooper Companies during the fourth quarter worth approximately $302,000. Cigna Investments Inc. New purchased a new position in shares of Cooper Companies during the fourth quarter worth approximately $321,000. Finally, Congress Asset Management Co. MA purchased a new position in shares of Cooper Companies during the fourth quarter worth approximately $50,411,000. 97.44% of the stock is currently owned by hedge funds and other institutional investors.
COO has been the subject of a number of analyst reports. Zacks Investment Research cut Cooper Companies from a “buy” rating to a “hold” rating in a report on Monday, November 21st. Jefferies Group LLC reissued a “buy” rating and set a $210.00 price objective on shares of Cooper Companies in a report on Wednesday, December 7th. BMO Capital Markets set a $203.00 price objective on Cooper Companies and gave the company a “buy” rating in a report on Friday, December 9th. Oppenheimer Holdings Inc. set a $188.00 price objective on Cooper Companies and gave the company a “hold” rating in a report on Friday, December 9th. Finally, Wells Fargo & Co raised Cooper Companies from a “market perform” rating to an “outperform” rating in a report on Monday, December 12th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $206.75.
Cooper Companies Company Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with our FREE daily email newsletter.